Last reviewed · How we verify
NCT07341438: PANDA
Physical Activity in the Management of Personality Disorders
NA trial testing Karate in Borderline Personality Disorder (BPD) in 60 participants. Currently enrolling.
1 November 2026
Quick facts
| Lead sponsor | Julie Midtgaard |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 February 2026 |
| Primary completion | 1 November 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- Karate
- Pedometer-based walking
- Treatment as usual (TAU) — full drug profile →
Conditions studied
- Borderline Personality Disorder (BPD) — all drugs for Borderline Personality Disorder (BPD) →
- Avoidant Personality Disorders — all drugs for Avoidant Personality Disorders →
Sponsor
Julie Midtgaard
Who can join
18 and older, any sex, with Borderline Personality Disorder (BPD) or Avoidant Personality Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The PANDA trial is studying whether two types of physical activity - a walking program and supervised karate training - are safe, acceptable, and possible for adults with certain personality disorders. The goal is to see if these activities can help people while being safe and easy to do. Who can take part: * Adults with borderline personality disorder or avoidant/anxious personality disorder. * People receiving treatment at two outpatient mental health clinics in the Capital Region of Denmark. * The study plans to include about 60 participants. What will happen in the study: Participants are randomly assigned to one of three groups: * Usual treatment only (control group). * Usual treatment plus walking program: an 8 - week pedometer - based program with goal setting and follow-up sessions. * Usual treatment plus supervised karate training: an 8 - week program led by experienced instructors. What the study will look at: * Main goal: Check if the programs can be done as planned, including whether participants attend sessions, follow the program, and stay safe. * Other outcomes: Possible changes in physical health, fitness, emotions, personality symptoms, body image, and daily activity. * Data will be collected through physical tests, questionnaires, and follow-up interviews about participants' experiences and motivation. * Measurements will take place at the start, after 8 weeks, and after 12 weeks (follow-up questionnaires only). Why this study is important: The results will help researchers decide if it is possible to run a larger study in the future to see if walking or karate training can improve health and wellbeing for people with personality disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07341438
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Karate
Trials testing the same drug.
- NCT07116291 — Impact of Regular Karate Practice on the Quality of Life and Health Outcomes of Students · NA · recruiting
Other recruiting trials for Borderline Personality Disorder (BPD)
Currently open trials in the same condition.
- NCT06699732 — Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patient · NA · recruiting
- NCT06195553 — Application and Effectiveness of the STEPPS in Patients with BPD, Extending to Their Families with the FC Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07341438 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Julie Midtgaard
- Last refreshed: 3 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07341438.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing